2 completed, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Withdrawn 1 |
Follow Alphagan: new trials by email Literature Review of Alphagan trials Research Report on Alphagan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brimonidine for Intraoperative Hemostasis Brimonidine Topical - Dermatochalasis of Eyelid, Ptosis, Eyelid | Phase 4 | Withdrawn | University of Louisville | 2022-05-26 | 2025-01-15 | |
| The Effect of Brimonidine Brimonidine, Tropicamide, Phenylephrine Ophthalmic Product - Intraocular Pressure | Phase 4 | Completed | Wake Forest University Health Sciences | 13 | 2019-07-20 | 2024-02-01 |
| Comparison of Istalolâ„¢ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) Istalol and Optive, Alphagan - Ocular Hypertension, Open-Angle Glaucoma | Phase 4 | Completed | Bp Consulting, Inc | 40 | 2008-06-01 | 2008-12-04 |
Blepharoptosis (1) · Ectropion (1) · Entropion (1) · Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
Bp Consulting, Inc (1) · University of Louisville (1) · Wake Forest University Health Sciences (1)
United States (3)
Christopher Compton, MD (1) · Jason Bacharach, M.D (1) · Keith Walter, MD (1)